Barclays
CVRX icon

Barclays’s CVRx CVRX Stock Holding History

Barclays’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.4K Sell
3,003
-22,259
-88% -$163K ﹤0.01% 4497
2025
Q4 		$179K Buy
25,262
+2,257
+10% +$20.6K ﹤0.01% 4382
2025
Q3 		$186K Sell
23,005
-5,872
-20% -$44.2K ﹤0.01% 4360
2025
Q2 		$170K Buy
28,877
+12,319
+74% +$85K ﹤0.01% 4375
2025
Q1 		$203K Sell
16,558
-4,820
-23% -$68.1K ﹤0.01% 4022
2024
Q4 		$271K Buy
21,378
+2,311
+12% +$28.5K ﹤0.01% 4163
2024
Q3 		$168K Buy
19,067
+14,445
+313% +$131K ﹤0.01% 4381
2024
Q2 		$55.4K Sell
4,622
-3,271
-41% -$37.7K ﹤0.01% 4168
2024
Q1 		$144K Sell
7,893
-7,386
-48% -$175K ﹤0.01% 4283
2023
Q4 		$480K Buy
15,279
+13,317
+679% +$250K ﹤0.01% 3902
2023
Q3 		$29.8K Sell
1,962
-254
-11% -$4.18K ﹤0.01% 4059
2023
Q2 		$34.2K Sell
2,216
-54,463
-96% -$665K ﹤0.01% 3996
2023
Q1 		$528K Buy
+56,679
New +$750K ﹤0.01% 3233
2022
Q2 		– Sell
-1,802
Closed -$11K – 5070
2022
Q1 		$11K Buy
+1,802
New +$14.5K ﹤0.01% 4582

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GP
GSK plc London $599M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's CVRX Position: Q1 2026 in Review

Barclays reduced its CVRx (CVRX) stake by 88% in Q1 2026, selling an estimated $163K and leaving 3,003 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4497.

Barclays first reported a position in CVRX in Q1 2022 and has held it in 14 quarters since. The position peaked at $528K in Q1 2023. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

  • Barclays held 3,003 shares of CVRx worth $28.4K as of Q1 2026.
  • Barclays sold 22,259 CVRx shares in Q1 2026, an estimated $163K.
  • CVRx made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4497 holding.
  • Barclays first reported a position in CVRx in Q1 2022 and has held it in 14 quarters since.
  • Barclays's CVRx position peaked at $528K in Q1 2023.
  • 99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.